TG Therapeutics, Inc.
NASDAQ: TGTX0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Capital Market
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Michael S. Weiss
- Employees
- 352
- Headquarters
- Morrisville, United States
- IPO year
- 2010
- Market cap
- $8.1B
- Website
- https://www.tgtherapeutics.com
Loading TGTX…
Loading profile data…Frequently asked questions about TGTX
What does TG Therapeutics, Inc. (TGTX) do?
Based in New York City and established in 1993, TG Therapeutics, Inc. is a biopharmaceutical company that has advanced to the commercial stage. Its core mission revolves around the acquisition, advancement, and marketing of novel therapeutic solutions. The company's focus areas specifically include B-cell related cancers (malignancies) and vario...
Where does TGTX trade?
TG Therapeutics, Inc. (TGTX) trades on the NASDAQ Capital Market.
What sector is TGTX in?
TG Therapeutics, Inc. (TGTX) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of TG Therapeutics, Inc.?
Michael S. Weiss is the chief executive officer of TG Therapeutics, Inc. (TGTX).
Where is TG Therapeutics, Inc. headquartered?
TG Therapeutics, Inc. is headquartered in United States.
Does TGTX pay a dividend?
TG Therapeutics, Inc. (TGTX) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did TGTX go public?
TG Therapeutics, Inc. (TGTX) completed its initial public offering in 2010.